Clinical trial
Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis
NCT00354510 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00354510 |
|---|---|
| Title | Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis |
| Official title | Randomised, Double-blind, Placebo-controlled Study of Topical GW842470X Formulation in Adults With Moderate Atopic Dermatitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis, Dermatitis, Atopic |
| Intervention type | Drug |
| Interventions | GW842470X cream |
| Enrollment | 190 |
| Start date | Mar 1, 2006 |
| First posted | Jul 20, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | Germany, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: